Global Churg-Strauss Syndrome Treatment Market, By Indication (Acute Ischemic Stroke, Cerebral Insufficiency, Alzheimer's Disease, Attention Deficit-Hyperactive Disorder (ADHD), Others), Diagnosis (Blood Test, Imaging, Biopsy, Chest X-ray, CT Scan), Treatment (Biologics, Immunoglobulin, Vaccines, Steroid, Corticosteroid, Immunosuppressive Drugs, Others), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies), End Users (Hospitals, Laboratories,  Clinics, Therapeutic Usage, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028